New search | Conferencedetail
Print view
 
 

4th Annual Neuropsychiatric Drug Development Summit | September 28-30, 2021 | Digital

Evvnt Promotion / evvnt
-
28.09.2021 - 30.09.2021  Online
Time: 8:30 am - 5:00 pm
 
Conference themes
This last year has been a brutal reminder as to how crucial it is that we tackle the impending global mental health crisis and find a path towards successful neuropsychiatric drug development. We are proud to be the industry’s definitive and unrivalled forum focused on encapsulating the recent clinical advances across this extremely arduous field.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/791022-3?pid=4832

Speakers: Heather Dworak Senior Director, Clinical Research Sunovion, Daniel Mathalon Professor of Psychiatry and Behavioral Sciences UCSF Weill Institute for Neurosciences and more
 

Enquiries and Registration:

https://go.evvnt.com/791022-2?pid=4832
Mr. Customer Service
 
Categories
General Medicine
Languages
English
Congress fees
Conference + 1 Workshop - Drug Developer: USD 2898.00, Conference Only - Drug Developer: USD 2399.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichische Akademie der ÄrzteAMREF - African Medical and Research FoundationÄrztekammer für WienÖsterreichisches Rotes KreuzSwiss Tropical and Public Health InstituteÄrzte der WeltEuropean Public Health Association (EUPHA)Charité International Academy